TMPRSS2 and prostate adenocarcinoma: To probe the cause of the increased TMPRSS2 in PRAD, we studied the methylation levels of TMPRSS2 in PRAD and found that the promoter methylation levels of TMPRSS2 in LUAD decreased significantly.